✦ LIBER ✦

POB3 EVALUATION OF THE COST-UTILITY OF ORLISTAT (XENICAL) IN THE UNITED KINGDOM

✍ Scribed by P McEwan; M Jones; C Farina; CJ Currie

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

POB3 COST-UTILITY ANALYSIS OF RIMONABANT

✍ C Hampp; AG Hartzema 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 46 KB

PDB27 A COST-UTILITY ANALYSIS OF ORLISTA

✍ JM Sverre; FKO Kristensen; LB Holm; K Nyhus 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

Orlistat for the treatment of obesity: c

✍ D. R. Foxcroft 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB

PUK9 EVALUATION OF THE COST UTILITY OF S

✍ CJ Currie; S Dixon; P Conway; P McEwan 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB

POB3 A PROBABILISTIC BAYESIAN MARKOV MOD

✍ S lannazzo; L Pradelli 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB

PND25 The Role of Structural Sensitivity

✍ A.E. Ratcliffe 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB